
Putting the dynamics into compound profiling: using kinetic assays to shape drug discovery
Dr Nick Holliday is Chief Scientific Officer (CSO) at Excellerate Bioscience, a contract research organisation for in vitro pharmacology. He will be presenting this webinar, hosted by DDW and supported by SPT Labtech. To register for free click here. “In vitro early stage compound profiling often focusses on single… Read More














